Webis Holdings PLC Jim Mellon joins the Webis board

RNS Number : 7243V

Webis Holdings PLC

10 July 2024

 

For immediate release

10 July 2024

Webis Holdings plc

("Webis" or the "Group")

Jim Mellon joins the Webis board

Following regulatory approval, the Board of Webis, the global gaming group, is pleased to announce the appointment of Mr James ("Jim") Mellon as a Non-Executive Director of the Group. Jim is a well-known entrepreneur, investor, and author. His interests include biopharma, life sciences, property, mining, and financial services amongst others. Jim is an honorary Fellow of Oriel College, Oxford and holds a master's degree in Politics, Philosophy and Economics from Oxford University. Jim is the beneficial owner of and Chairman of Burnbrae Group Limited.

Ed Comins, Webis' Managing Director, commented:

"I am delighted to welcome Jim to the Board of Webis. His exceptional commercial experience will prove invaluable as we continue to implement our strategy, and we are sure he will make a very positive contribution to the Board."

James ("Jim") Mellon (age 67)

He has held the following directorships and/or partnerships in the past five years:

Current	Past
Acruity Limited	Binary Group Ltd
Agronomics Investment Holdings Limited	Binary Investments (Europe) Limited
Agronomics Limited	Binary Limited
Albany Management Limited	Biogerontology Research Foundation
American Federation of Aging Research	Calabrese Holdings Limited
Big Group Limited	Extreme Opportunities Limited
Bradda Head International Limited	Fast Forward Innovations Limited
Bradda Head Limited	Ferrum Limited
Bradda Head Lithium Limited	Fixed-Odds Capital (Cook Islands) Ltd
Buck Institute for Research on Aging	Global Glory Investment Limited
Burnbrae Germany East GmbH	Insilico Medicine Cayman Subco
Burnbrae Germany Limited	Insilico Medicine Cayman Topco
Burnbrae Germany Operations GmbH	Insilico Medicine Hong Kong Limited
Burnbrae Germany West GmbH	Insilico Medicine, Inc.
Burnbrae Group Limited	Interman (Hong Kong) Limited
Burnbrae Limited	Plethora Solutions Holdings plc
Burnbrae Mitte GmbH	Regent Corporate Finance Limited
Burnbrae Sachsen GmbH	Regent Fund Management (Asia) Limited
Calabrese Holdings Limited	Regent Fund Management Limited
Clean Air Capital Limited	Regent Metals Holdings Limited
Clean Food Group Limited	Shaanxi Red Dragon Resources Ltd
Compedica Holdings Limited	Speymill Deutsche Immobilien plc
Condor Gold Plc	Speymill Property Group (UK) Limited
Good Dog Food Limited	Wielandstrasse 5 Objekt GmbH
IC Technology (UK) Limited
J2 Music Limited
Juvenescence Limited
LyGenesis, Inc.
Mann Bio Pathfinder Limited
Mann Bioinvest (BVI) Limited
Mann Bioinvest Limited
Manx Financial Group plc
MediqVentures Limited
New Agrarian Company Advisors Limited
New Agrarian Company Limited
Podenco Global Limited
Portage Biotech, Inc
Powered Future Limited
Regent Pacific Group Limited
SABR Holdings Litd
SalvaRx Group Limited
SalvaRx Group PLC
SalvaRx Limited
Shellbay Investments Limited
Sleepwell Hotels (UK) Limited
Sleepwell Hotels Limited
The Longevity Forum Limited
Titec (BVI) Limited
Winter Limited
Wolseley Managers Limited

 

Jim Mellon holds 248,204,442 shares in the Group in the name of Burnbrae Limited, representing 63.1% of the issued capital.

Further information on Mr Mellon which required to be disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies is set out in the Appendix.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

For further information:

Webis Holdings plc Tel: [phone]

Denham Eke

Beaumont Cornish Limited Tel: [phone]

Roland Cornish/James Biddle

Appendix: Further disclosure under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies

Jim Mellon was a director of Regent Global Fund and Undervalued Assets Greater China Fund Series III, both of which went into voluntary liquidation. These two funds were liquidated with the consent of shareholders as the directors recommended that, due to a decline in the size of the funds, they were uneconomic. There were no unsatisfied creditors.

Bigsave Holdings plc, a company of which Jim Mellon was a director, entered into a voluntary liquidation. There were no unsatisfied creditors.

On 8 April 2003, Regent Pacific Fund, a company of which Jim Mellon was a director, entered into a voluntary liquidation. There were no unsatisfied creditors.

On 9 December 2005, Undervalued Assets Fund - Series One, a company of which Jim Mellon was a director, entered into a voluntary liquidation. There were no unsatisfied creditors.

On 5 February 2008, Asian Opportunity Fund 1998 - Series I, commenced voluntary liquidation pursuant to its Articles and Association. Jim Mellon was a director within the 12 month periods preceding such date. There were no unsatisfied creditors.

On 29 January 2014, Rivington Street Holdings plc, a company of which Jim Mellon was a director, entered into a voluntary liquidation. The creditors were owed approximately £4 million, of which Jim Mellon and his interests were owed £3.8 million.

On 3 September 2015, Speymill plc, a company of which Jim Mellon was a director, entered into a voluntary liquidation and was subsequently dissolved on 6 July 2017. The combined creditors of the Speymill Group were approximately £4.3 million, of which Jim Mellon and his interests were owed £3.9 million.

There was an historic arrest warrant for Jim Mellon, issued by the Seoul South Korea prosecutor's office on 19 December 2000 and subsequently reissued on 14 January 2004. The warrant was due to remain valid and effective until 12 March 2010. The arrest warrant pertains to an alleged involvement in a conspiracy to manipulate the share price of Regent Securities Co., Ltd. Mr Mellon has informed the Company that he absolutely and categorically denies that this allegation has any substance. No evidence was produced against him and no further proceedings have taken place with no further developments in this matter since 2010.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

BOAUKUURSVUBRAR